| Literature DB >> 34894974 |
Susanna B Park1, Stefano Tamburin2, Angelo Schenone3,4, Ian R Kleckner5, Roser Velasco6,7, Paola Alberti8, Grace Kanzawa-Lee9, Maryam Lustberg10, Susan G Dorsey11, Elisa Mantovani2, Mehrnaz Hamedani3, Andreas A Argyriou12, Guido Cavaletti8, Ahmet Hoke13.
Abstract
INTRODUCTION: Chemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and physical activity-based interventions have demonstrated promise in reducing existing CIPN symptoms and potentially preventing toxicity, however there is a significant gap in evidence due to the lack of quality clinical trials and appropriate outcome measures. AREAS COVERED: We systematically reviewed outcome measures in CIPN exercise and physical rehabilitation studies with expert panel consensus via the Peripheral Nerve Society Toxic Neuropathy Consortium to provide recommendations for future trials. Across 26 studies, 75 outcome measures were identified and grouped into 16 domains within three core areas - measures of manifestations of CIPN (e.g. symptoms/signs), measures of the impact of CIPN and other outcome measures. EXPERT OPINION: This article provides a conceptual framework for CIPN outcome measures and highlights the need for definition of a core outcome measures set. The authors provide recommendations for CIPN exercise and physical rehabilitation trial design and outcome measure selection. The development of a core outcome measure set will be critical in the search for neuroprotective and treatment approaches to support cancer survivors and to address the gap in the identification of effective rehabilitation and treatment options for CIPN.Entities:
Keywords: Chemotherapy induced peripheral neurotoxicity; cancer survivorship; exercise; neurotoxicity; outcome measures; peripheral neuropathy; rehabilitation; treatment
Mesh:
Substances:
Year: 2022 PMID: 34894974 PMCID: PMC8963967 DOI: 10.1080/14737175.2022.2018300
Source DB: PubMed Journal: Expert Rev Neurother ISSN: 1473-7175 Impact factor: 4.287